Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic myelogenous leukemia: an overview.

L Tennant

    Clinical Journal of Oncology Nursing
    |March 20, 2002
    PubMed
    Summary
    This summary is machine-generated.

    Treatment for chronic myelogenous leukemia (CML) has advanced significantly, now including multiple therapies. Ongoing research promises even more options for CML patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Determination of Fe-ligand bond lengths and the Fe-N-O bond angles in soybean ferrous and ferric nitrosylleghemoglobin a using multiple-scattering XAFS analyses.

    Biochemistry·1999
    Same author

    Chemical shift as a probe of molecular interfaces: NMR studies of DNA binding by the three amino-terminal zinc finger domains from transcription factor IIIA.

    Journal of biomolecular NMR·1998
    Same author

    Probing protein structure using biochemical and biophysical methods. Proteolysis, matrix-assisted laser desorption/ionization mass spectrometry, high-performance liquid chromatography and size-exclusion chromatography of p21Waf1/Cip1/Sdi1.

    Journal of chromatography. A·1997
    Same author

    Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity.

    Proceedings of the National Academy of Sciences of the United States of America·1996
    Same author

    1H, 15N and 13C resonance assignments for the first three zinc fingers of transcription factor IIIA.

    Journal of biomolecular NMR·1994
    Same author

    Electrostatic calculations of side-chain pK(a) values in myoglobin and comparison with NMR data for histidines.

    Biochemistry·1993

    Area of Science:

    • Hematology
    • Oncology
    • Pharmacology

    Background:

    • Chronic myelogenous leukemia (CML) treatment has evolved over the past two decades.
    • Current CML management involves hydroxyurea, interferon, tyrosine kinase inhibitors, and stem cell transplantation.

    Purpose of the Study:

    • To review the significant advances in chronic myelogenous leukemia (CML) treatment.
    • To highlight the increasing complexity in managing CML patients due to diverse therapeutic options.

    Main Methods:

    • Literature review of CML treatment modalities.
    • Analysis of therapeutic advancements in the last 20 years.

    Main Results:

    • Multiple effective therapies are now available for CML.

    Related Experiment Videos

  • The availability of diverse treatments has increased the complexity of patient care.

    • Conclusions:

    • Continued research and drug development are crucial for CML.
    • Future therapies are expected to offer expanded treatment options and hope for CML patients.